BioSpace News Archive

Acorda Therapeutics, Inc. provided a financial update for the quarter ended September 30, 2019..

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, announced its financial results for the third quarter ended September 30, 2019.

Synthetic Biologics, Inc. provided an operational update and reported financial results for the three and nine months ended September 30, 2019.

Paul Campanelli Appointed Chairman of the Board, Will Also Continue as President and Chief Executive Officer Until Successor Appointed; Roger Kimmel Appointed Senior Independent Director

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted seven newly-hired employees options to purchase an aggregate of 26,400 shares of Akebia’s common stock on October 31, 2019, as inducements material to each such employee’s entering into employment with Akebia.

Company to Host a Zimura® R&D Symposium for Investors on November 20, 2019

2020 Mom Founder and Executive Director Joy Burkhard has been awarded the 2019 American Public Health Association (APHA) Maternal and Child Health Outstanding Leadership & Advocacy Award for her tireless advocacy efforts leading maternal mental health awareness and systems change at national, state and local levels.

Collaboration supports joint customers’ adoption of Azure Digital Twins

United Health Products, Inc. will host a corporate update conference call on Thursday, November 7, 2019 at 11:00 am Eastern Time.

UMA team members chaired the event, shared stories of survival, walked in support and raised funds to further cancer research